Market Research Blog – Page 1352 – New Product Development

Indian Hemostat Market Projected to Grow at 5.8% CAGR, Expected to Reach New Heights by 2025

The Indian hemostat market, valued at USD 54.1 million in 2015, is anticipated to experience significant growth over the next decade. The market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 5.8% from 2016 to 2025. This growth is driven by advancements in hemostat products and increasing adoption among medical practitioners and surgeons, fueled by a rise in surgeries and trauma cases across the country.

The surge in market growth is attributed to ongoing innovations in hemostat technology and the growing recognition of the critical role these products play in managing bleeding during medical procedures. As the number of surgeries and trauma cases continues to increase, the demand for effective hemostat solutions is expected to rise correspondingly.

However, India hemostat market is projected to register a healthy CAGR of 5.8% during the forecast period owing to factors such as benefits offered by these products and creating product image of hemostat among key opinion leaders such as healthcare professionals. Moreover, increasing number of accidents and trauma injuries is expected to drive growth of the India hemostat market during the forecast period. This report assesses trends driving growth of each segment in the market, and offers potential takeaways and strategic recommendations for manufacturers seeking to enter the market.

This report covers the India hemostat market and various segments in terms of revenue contribution. The report also includes FMI’s analysis of key trends, drivers, restraints and opportunities that are influencing growth of the India hemostat market. Impact analysis of key growth drivers and restraints is included in this report to better equip clients with crystal-clear decision-making insights.

The hemostat market is segmented based on product type, product material base, applications and distribution. Based on product type, the market has been segmented into mechanical product type and flowable product type. The mechanical type segment is expected to register a CAGR of 6.0% during the forecast period. Flowable type segment is expected to witness a decline in market share in terms of revenue from 11.7% in 2015 to 10.1% in 2025. Overpriced products is expected to affect demand for hemostat products over the forecast period.

Basically there are two product material base; gelatin base and oxidised cellulose base, gelatin base comprises of 77.0% market share of hemostat market in India owing to maximum usage of gelatin in all hemostat products as it has property of absorbing blood flow at a faster speed and healing the wound.

Furthermore hemostat products are segmented into application, surgeries and trauma cases. Surgery segment is expected to witness a decline in market share in terms of revenue from 63.7% in 2015 to 61.8% in 2025. The trauma cases segment is expected to expand at the highest CAGR of 6.3% over the forecast period.

The market has also been segmented by distribution channel into hospitals, ambulatory surgical centres, clinics and online channels. The hospitals segment followed by ambulatory surgical centres is expected to account for the highest demand for hemostat products over the forecast period, registering a CAGR of 7.0% and 5.7%.

Due to reimbursement for surgeries by insurance payers and increased in adoption of hemostat products by medical practitioners and surgeons. To reach out to the consumers and healthcare professionals manufacturers are supplying products through E-Commerce which is expected to push demand for hemostat products in the online channel over the forecast period.

Furthermore, Future Market Insights has developed market attractiveness index for all four segments: product type, product base, application and distribution channel segments. This index helps in identifying the real opportunities in the market.

Key market players covered in this report

Johnson and Johnson (Ethicon), Baxter, Aegis Lifesciences, Eucare Pharmaceuticals and Mil Laboratories. Major players are focusing on enhancing their regional presence through strategic mergers & acquisitions and by expanding operations.

A Full Report – Overview

Key Segments Covered

Segmentation on basis of Product Type

Mechanical type
Flowable type

Segmentation on basis of Product Material Base

Gelatin
Oxidized cellulose

Segmentation on basis of Application

Surgery
Trauma cases

Segmentation on basis of Distribution Channel

Hospitals
Ambulatory Surgical Centers
Clinics
Online Channels

Segmentation on basis of Geography
India

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Auto-Injectors Market Set for Significant Growth, Projected to Reach USD 67,200.1 Million by 2033 at a 8.2% of CAGR

In 2023, the global auto-injectors market is poised to achieve a substantial valuation of USD 30,578.2 million, underscoring its pivotal role within the healthcare sector. The market’s impressive growth trajectory is expected to continue, with projections indicating a surge to approximately USD 67,200.1 million by 2033. This remarkable increase highlights the growing significance of auto-injectors in delivering effective medical treatments.

The auto-injector market is anticipated to expand at a commendable compound annual growth rate (CAGR) of 8.2% from 2023 to 2033. This robust growth rate reflects the rising reliance on auto-injectors for the administration of a wide range of medications, from life-saving drugs to biologics. The device’s ability to offer convenience, accuracy, and efficiency in medication delivery is driving its increasing adoption.

The period from 2018 to 2022 saw an accelerated CAGR of 11.6%, reflecting the rapid adoption and integration of auto-injectors into healthcare practices. This past growth trajectory underscores the evolving demand for these devices, driven by advancements in technology and an increasing emphasis on patient-centric treatment solutions.

As the global healthcare landscape evolves, the demand for efficient, user-friendly drug delivery systems like auto-injectors continues to expand. The projected market growth underscores the critical role of auto-injectors in enhancing patient outcomes and streamlining medical procedures.

“The growing adoption of auto-injectors among healthcare experts is opening up intriguing possibilities for their application in diverse medical scenarios.”- says an FMI analyst

The development of connected and smart auto-injectors is a major trend in the automotive industry. These gadgets improve treatment monitoring and patient engagement by sending usage data and patient information to healthcare providers. Furthermore, home-use auto-injectors are becoming more and more common, enabling patients to effortlessly administer their own prescriptions. Pharmaceutical companies and auto-injector manufacturers are working together to create co-branded devices for certain treatments, which guarantees precise and user-friendly drug administration.

Key Takeaways from the Auto-Injectors Market:

Prefilled auto-injectors dominate the market, commanding an impressive share of 86.30% in 2023.
The anaphylaxis indication Segment exhibits remarkable strength, capturing an overwhelming share of 88.7% in 2023.
The United States auto-injectors market boasts a substantial share of 29.10% in 2023.
Germany established a notable market share of 8.80% in 2023.
Japan claims a respectable market share of 1.60% in 2023.
Australia secures a significant market share of 5.60% in 2023.
China showcases its market prowess with a substantial share of 8.00% in 2023.
India also feels its impact with a substantial market share of 8.30% in 2023.

Key Players in the Auto-Injectors Market Striving for Better Revenue Prospects

The auto-injectors industry boasts a highly competitive landscape with several prominent players vying for market share. Some notable participants include Becton, Dickinson, Company, Sanofi, Pfizer, Inc., Mylan N.V., and Novartis AG. These companies have established their dominance through innovative product offerings and strategic partnerships. Moreover, their extensive global presence enables them to cater to a wide range of therapeutic areas and patient populations.

Another key trend in the competitive landscape is the formation of strategic collaborations between pharmaceutical companies and auto-injector manufacturers. This collaboration results in co-branded devices for specific medications, ensuring precise and user-friendly drug delivery.

This approach has created a win-win situation, with pharmaceutical companies gaining a competitive edge by offering differentiated delivery solutions and auto-injector manufacturers benefiting from increased product demand. As the industry continues to evolve, these partnerships are expected to shape the competitive landscape further, driving innovation and expanding market reach.

Key Companies in the Market:

Becton, Dickinson, and Company
Sanofi
Pfizer, Inc
Mylan N.V.
Novartis AG
Bayer AG
Janssen Global Services, LLC
Antares Pharma, Inc.
Amgen Inc
Eli Lilly and Company
Teva Pharmaceutical
Merck KgaA
GlaxoSmithKline plc
Ypsomed
SHL Medical
Gerresheimer AG
Midas Pharma GmbH
Aptar Pharma
Solteam Medical
Stevanato Group
E3D
West Pharmaceutical Services, Inc

A Old Full Report Analysis Click Here

Key Segments:

By Product:

Prefilled Auto-Injectors
Fillable Auto-Injectors

By Indication:

Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Middle East Veterinary Vaccine Market Set for Growth, Projected to Reach USD 973.8 Million by 2033 at a 4% of CAGR

Middle East Veterinary Vaccines Industry

The Middle East veterinary vaccine industry is on track for significant growth, with projections indicating an expansion at a compound annual growth rate (CAGR) of 4% through 2033. The market, valued at USD 627.1 million in 2023, is expected to surpass USD 973.8 million by the end of the forecast period.

This anticipated growth reflects a rising demand for veterinary vaccines across the region, driven by several key factors. Increasing awareness of animal health and welfare, coupled with advancements in vaccine technology, is propelling the need for effective vaccination solutions. Veterinary vaccines play a crucial role in preventing and controlling diseases among livestock and companion animals, thereby supporting both animal health and public safety.

This growth is driven by increasing awareness of animal health, advancements in veterinary medicine, and a rising demand for effective vaccines to combat animal diseases across the region. The Middle East is experiencing an upsurge in investment in veterinary healthcare infrastructure, which is further fueling the demand for innovative vaccine solutions.

The rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This will fuel the demand for effective vaccination of livestock, especially in major animal farming and meat-producing nations in the region with a diversified herd such as Sudan, Turkey, Egypt, and KSA.

Rising per capita disposable income levels are largely contributing to the demand for processed food items. This is expected to drive the growth of veterinary vaccines in poultry and livestock segments.

The key players in the veterinary vaccine industry are focusing on finding innovative products to control zoonotic infection rates. Along with this, various advancements in biotechnology are expected to create a favorable platform for the development of various veterinary vaccines in developing markets such as UAE, KSA, Turkey, and Jordan. These techniques include next-generation sequencing, synthetic biology, and systems biology, among others.

Further, continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency and shorten the time-to-market for upcoming veterinary vaccines.

Key players are working on innovative products, conducting acquisitions, mergers, and agreements with other companies to improve their market presence and tap into less competitive emerging markets.

For instance, In September 2018, Boehringer Ingelheim announced that they would be donating 75,000 doses of rabies vaccines to the Global Alliance for Rabies Control, as an effort to recognize World Rabies Day on September 28^th.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level and help companies to sustain the increasing competitive pressure.

Key Takeaways from the Middle East Veterinary Vaccines Industry Study

The Middle East veterinary vaccine market is expected to grow consistently, reaching a projected value of US$ 973.8 million by 2033.
This growth is driven by a CAGR of 4%, indicating a steady increase in demand for veterinary vaccines.
The current market size stands at US$ 627.1 million in 2023, highlighting the existing base for further expansion.

“Increased demand for processed meat products around the world will drive the demand for veterinary vaccines market in the Middle East,” says the FMI Analyst.

Who is winning?

The key manufacturers of the veterinary vaccines market are adopting strategies such as partnership strategies for global expansion and improving their hold over the global market.

In January 2021, Merck Animal Health announced the acquisition of Poultry Sense Ltd, which provides health and environmental monitoring solutions for the poultry industry.
In September 2019, Ceva, in partnership with Biotecon Diagnostics, announced the launch of their latest product, a real-time diagnostic kit that will help poultry producers fight salmonella infections in their farms.

The key market players of the Middle East veterinary vaccines market include :

JOVA, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc, Bayer Pharma AG, Ceva and Boehringer Ingelheim.

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The Middle East veterinary vaccines market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into the Middle East veterinary vaccines market. The veterinary vaccines market is segmented into five parts based on vaccine type (attenuated live vaccines, inactivated vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines, and others) based on animal type (companion animals, livestock animals, and equine) based on disease indication (foot and mouth disease, Newcastle disease, PPRS, canine parvovirus, brucellosis, avian influenza, and others), based on end-user (hospital pharmacies, veterinary clinics, private veterinary pharmacies and others) and based on country ( KSA, UAE, Turkey, Jordan, Sudan, Egypt and Rest of MEA).

A Old Full Report Analysis Click Here

Middle East Veterinary Vaccines Industry, by Category

By Vaccine:

Attenuated Live Vaccines
Inactivated Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Others

By Animal:

Companion Animals
- Canine
- Avian
- Feline
Livestock Animals
- Aquatic
- Bovine
- Porcine
- Small Ruminant
- Poultry
Equine

By Disease Indication:

Foot and Mouth Disease
Newcastle Disease
PPRS
Canine Parvovirus
Brucellosis
Avian Influenza
Others

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Orthopedic Imaging Equipment Market Set to Surge, Expected to Reach USD 14.6 Billion by 2031 at a 4.0% of CAGR

The global orthopedic imaging equipment market, valued at USD 9.8 billion in 2021, is poised for significant growth, with projections indicating it will reach USD 14.6 billion by 2031. This expansion reflects a robust compound annual growth rate (CAGR) driven by the rising prevalence of accidents and sports injuries leading to fractures and bone injuries.

The growing frequency of orthopedic conditions due to an increase in physical activities and accidents is fueling demand for advanced diagnostic imaging technologies. Orthopedic imaging plays a crucial role in accurately diagnosing bone and joint issues, enabling timely and effective treatment. As sports participation rises and road traffic accidents remain prevalent, the need for sophisticated imaging solutions is becoming more pronounced.

The surge in market demand is closely linked to the escalating need for advanced diagnostic imaging technologies in orthopedic care. As the frequency of such injuries continues to rise, so does the necessity for accurate and efficient imaging solutions that aid in precise diagnosis and treatment planning.

Rising prevalence of Orthopaedic diseases and bone injuries, technological advancement in Orthopaedic imaging equipment devices, and rise in research and development activities by key manufacturers are factors driving the Orthopaedic imaging equipment market.

Numerous medical imaging modalities are currently enabling three-dimensional (3D) visualization with accuracy, and rapid diagnoses. Advancements in 3D imaging have led to development in computer-assisted detection (CAD) and image analysis applications. This is expected to boost the market for modality, primarily in tomographic imaging techniques.

Moreover, surgeons are using 3D imaging to plan surgeries, which has led to increased application of these systems. This is expected to increase the utilization of imaging equipment, especially across the U.S. and the U.K.

Consequently, these devices are also gaining high traction in Asia such as China and India due to growing demand for better health care infrastructure. Improving healthcare infrastructure and technological developments in these countries will increase the demand for 3D medical imaging equipment.

Key Takeaways from Orthopaedic Imaging Equipment Study

In terms of product type, the X-ray systems is expected to account for 28.0%, expanding at a CAGR of 3.3% during the forecasted period.
By indication, the acute injuries segment will contribute over 56.6% of sales in the global Orthopaedic imaging equipment market.
Hospitals and radiology centers will, collectively, account for 68.2% of the market share in 2021.
With the advancements in technologies as well as the increasing geriatric population, North America held the largest share of over 30.5% in 2021.
India and China are expected to lead the growth of South and East Asia in the global Orthopaedic imaging equipment market.

Who is winning?

The key market players covered by FMI include General Electric Healthcare Limited, Siemens AG, Esaote SPA, Hitachi Ltd, Koninklijke Philips N.V, PLANMED OY, EOS imaging, Canon Medical Systems Corporation, Carestream Health and Neusoft Corporation.

Some of the leading manufacturers of the Orthopaedic imaging equipment market are focusing on the development of advanced and cost-effective products establishing distribution agreements, collaborations and partnerships strategies for global expansion objectives, thereby, enhancing their market presence.

In September 2021, GE Healthcare acquired BK Medical for $1.45Bn to expand its $3bn ultrasound business from diagnostics to surgical and therapeutic interventions.
In April 2016, Hitachi Ltd Company integrated Hitachi Medical Corporation and Hitachi Aloka medical into Hitachi Ltd to strengthen its manufacturing operations and to develop low-cost medical devices.

A Old Full Report Analysis Click Here

Orthopedic Imaging Equipment Industry by Category

By Product:

X-Ray Systems
CT-Scanner
MRI Systems
EOS Imaging Systems
Ultrasound
Nuclear Imaging Systems

By Indication:

Acute injuries
- Sports injuries
- Trauma cases
Chronic Disorders
- Osteoarthritis
- Osteoporosis
- Prolapsed Disc
- Degenerative joint diseases
Others

By End-User:

Hospitals
Radiology Centers
Emergency Care Facility
Ambulatory Surgical Centers

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Aromatherapy Market Poised for Significant Growth, Projected to Reach USD 13,106.4 Million by 2034 at a 6.4% of CAGR

The global aromatherapy market is on track for remarkable growth, with a projected valuation of USD 7,048.0 million in 2024. The market is set to experience an encouraging expansion, anticipated to grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2034. By the end of the forecast period, the aromatherapy industry is expected to reach an impressive USD 13,106.4 million.

This anticipated growth reflects the increasing popularity of aromatherapy as a holistic approach to wellness and stress relief. Aromatherapy, which utilizes essential oils and plant extracts for therapeutic purposes, is gaining traction among consumers seeking natural and effective health and wellness solutions.

Key factors driving this growth include a rising awareness of the benefits of aromatherapy, expanding applications in personal care, mental health, and home wellness, and innovations in product offerings. As more people turn to natural therapies to complement their health routines, the demand for aromatherapy products is expected to continue its upward trajectory.

This growth reflects a burgeoning interest in holistic health practices and the increasing adoption of aromatherapy for wellness and therapeutic purposes. Factors driving this upward trend include heightened consumer awareness of natural remedies, a growing preference for stress-relief solutions, and the expanding application of essential oils in various health and beauty products.

Key Takeaways

Several wellness professionals including spa therapists, aroma therapists, massage therapists, and gym trainers, prefer single and blended essential oils for the treatment of insomnia, anxiety, pain, agitation, stress, and other conditions because essential oils provide the desired therapeutic effects with minimal or no side effects. This is due to the fact that these treatments may be conducted without the use of medicines.
One of the crucial driving factors propelling the growth of the global aromatherapy industry is known to be its strong distribution network. Various essential oil markers are working on negotiating distribution arrangements with large retail corporations to make their goods available, which will result in greater penetration of aromatherapy treatments and products.
Aromatherapies are rapidly being preferred these days attributing their properties for relaxation is likely to contribute to the aromatherapy market’s revenue development. The development of inhalation aromatherapy for the treatment of sleep issues such as insomnia is significant market advancement.

Competitive Landscape

Dominant aromatherapy product manufacturers are employing multi-level marketing tactics in order to enhance product distribution and they are also considering hiring a large number of independent distributors. This has resulted in increased accessibility and affordability of aromatherapy goods are likely to stimulate global demand for essential oils and aromatherapy diffuser products.

An extensive marketing network of distributors is expected to benefit both global and local market participants. In addition to that, firms are providing their aromatherapy goods online, which are projected to assist the aromatherapy market’s growth.

More Insights into the Aromatherapy Market

North America is expected to dominate the global aromatherapy market owing to the presence of crucial market competitors in the region. The growth in the region is also attributed to the surging sales of crucial oil for home use, lifestyle changes, a growing urban population, and the increased influence of the media are all factors boosting demand for aromatherapy goods in the region.

The aromatherapy market in Europe is expected to rise significantly over the forecast period. The rising popularity of aromatherapy as a therapeutic and pharmacological alternative is expected to drive market expansion in Europe. The majority of essential oils are sold in European nations including the United Kingdom, Germany, the Netherlands, Belgium, and Ireland.

Competitive Landscape in the Aromatherapy Market:

The aromatherapy market is heavily fragmented, with established companies tussling with local players in well-developed regions. The competition in the market is increasing with the experimentation done by market players to achieve dominance.

Market players are expanding geographically to increase market demand. Prominent player doTERRA is taking steps to expand into underdeveloped nations.

Recent Developments in the Aromatherapy Market

In March 2023, BASF planned expansion of its aroma ingredients facilities in Germany and China. The new manufacturing facility in Ludwigshafen will be concentrated on menthol and linalool downstream plants while the one in Zhanjiang was penned in for the citral plant.
In October 2022, International Flavors & Fragrances Inc. opened its innovation center in Singapore.
In September 2022, Young Living was the recipient of 17 essential oil production patents from the United States Patent and Trademark Office.
In April 2022, the WoodWick Radiance diffuser was launched by The WoodWick Candle Brand. The diffuser affords convenience to users because of its easy refueling process.
In March 2022, Saje Natural Wellness, in collaboration with The Little Market, unveiled a limited-edition diffuser called the Aroma Mosaic diffuser.

Key Companies in the Aromatherapy Market:

doTERRA
International Flavors & Fragrances Inc.
Symrise
Edens Garden
Young Living Essential Oils
Rocky Mountain Oil
Mountain Rose Herbs
Plant Therapy Inc.
Thann-Oryza Co. Ltd.
Isagenix International LLC

A Old Full Report Analysis Click Here

Key Segments:

By Product:

Aromatherapy Consumables
- Essential Oils
  - Floral
  - Citrus
  - Herbaceous
  - Spicy
  - Woodsy
  - Earthy
  - Camphorous
  - Others
- Blended Oils
- Carrier Oils
Aromatherapy Equipment
- Nebulizing Diffusers
- Ultrasonic Diffusers
- Evaporative Diffusers
- Heat Diffusers

By Application:

Relaxation
Insomnia
Pain Management
Scar Management
Skin & Hair Care
Cold & Cough
Others

By Mode of Delivery:

Topical Application
Direct Inhalation
Aerial Diffusion

By Distribution Channels:

Aromatherapy Products Sold at Retail Shops
Aromatherapy Products Sold through Online Channels
Direct Distribution of Aromatherapy Products

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Infusion Pump Market Set for Robust Growth, Projected to Reach USD 8,345.4 Million by 2034 with 5.4% of CAGR

The global infusion pump market is on a promising growth trajectory, with sales anticipated to increase from USD 4,688.2 million in 2023 to an estimated USD 8,345.4 million by 2034. This growth reflects a robust compound annual growth rate (CAGR) of 5.4% over the forecast period from 2024 to 2034.

In 2024, the infusion pump market is expected to be valued at USD 4,932.2 million, showing a year-over-year growth of 5.2%. This upward trend is fueled by significant advancements in infusion pump technology, including the development of more precise and user-friendly devices, which enhance patient care and streamline medical procedures.

This robust growth is driven by advancements in medical technology, increasing healthcare demands, and rising prevalence of chronic diseases requiring precise medication delivery. Infusion pumps, which are critical for administering fluids, medications, and nutrients, are seeing increased adoption across hospitals, clinics, and homecare settings.

The market for infusion pumps is driven primarily by the healthcare industry. Infusion pumps are essential in healthcare settings because controlling chronic diseases requires accurate and continuous medication delivery.

Innovations in drug delivery technology have also contributed to the market’s growth by producing infusion pumps with specialized features to meet a range of medical needs.

Several key trends are shaping the future of the infusion pump market:

Chronic Disease Management: The rising prevalence of chronic diseases like diabetes, cancer, and gastroenterological conditions is a major driver. These conditions often require long-term treatment, and infusion pumps play a vital role in administering medication effectively.
Shift to Home-Based Care: The increasing demand for home-based infusion therapies is another key factor. Infusion pumps offer a cost-effective and convenient alternative to hospital-based treatment, allowing patients to receive care in the comfort of their own homes. This trend is expected to continue fueling market growth.

Key Takeaways from the Market Study

The market valuation in 2022 was US$ 626
The market valuation in 2017 was US$ 543
Based on product type, volumetric pumps are expected to dominate at a value share of 22% in 2023.
India is estimated to register at a CAGR of 3.8% by 2033.
China experiences significant growth, projected at a CAGR of 3.3% by 2033.

“Rapid technological innovations are projected to encourage companies to develop more user-friendly and technologically advanced infusion systems and is considered a major driving factor of the infusion pump market,” comments a Future Market Insights analyst

Competitive Landscape

The infusion pump industry boasts a substantial array of market participants. Research and development play a pivotal role among these players, primarily focusing on introducing eco-friendly product lines as a core aspect of their manufacturing endeavors. Furthermore, they employ various expansion strategies, including collaborations, mergers and acquisitions, and diligent exploration of regulatory approvals to bolster their market presence.

Some of the key developments are

Voluntis, a prominent player in the healthcare software industry, joined forces with Biocon biologics to revolutionize diabetes management. The strategic partnership aims to develop and offer innovative digital therapeutics designed to support diabetes patients who rely on biologics therapy.
Mindray Medical expanded its product portfolio by introducing the BeneFusion e series. The new line includes eSP, eVP, and eDS infusion systems, representing a technological step forward. The introduction of these advanced infusion systems reflects Mindray Medical’s commitment to providing cutting-edge medical equipment to healthcare facilities.

Recent Developments

In 2023, Terumo Corporation revealed its plans to build a new manufacturing plant for its medical care solutions division. The facility will be located at the Kofu Factory premises situated in Yamanashi, Japan.
In 2023, Virginia Oncology Associates (VOA) procured the Ivenix Infusion System to deliver medications to its patients. This purchase was made under an agreement signed with Fresenius Kabi.
In 2023, Terumo Blood and Cell Technologies collaborated with BioCentriq to showcase how automated cell and gene therapy platforms from Terumo can expedite the development of CAR-T cells.

Key Market Players:

Terumo Corporation
Medtronic Plc
Smiths Medical
MOOG Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Terumo Corporation
CareFusion Corporation
ICU Medical, Inc.
Baxter International Inc.

A Old Full Report Analysis Click Here

Key Market Segmentation:

By Product Type:

Syringe Pumps
Small Volume Pump
Ambulatory Pumps
Volumetric Pumps
Peristaltic
Cassette/Piston
Implantable Pumps
Insulin Pumps
Enteral Pumps
PCA Pumps
Pump Accessories

By Modality:

Stationary Pumps
Infusion Pumps

By Application:

Chemotherapy/Oncology
Pediatrics/Neonatology
Analgesia
Gastroenterology
Hematology
Diabetes

By End User:

Hospitals
Ambulatory Surgical Centers
Home Care
Clinics
Others

By Region:

North America
Latin America
East Asia
South Asia
Europe
Oceania
MEA

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Wound Debridement Products Market Expected to Reach USD 7.52 Billion by 2033, Growing at 5.2% CAGR

The global wound debridement products market is set to experience significant growth, with an anticipated valuation of USD 4.54 billion in 2023 and a projected increase to USD 7.52 billion by 2033. This growth reflects a robust compound annual growth rate (CAGR) of 5.2% over the forecast period from 2023 to 2033.

Wound debridement is a crucial process in wound management, aimed at removing dead or contaminated tissue to promote healing and prevent infection. The demand for advanced debridement products is driven by increasing cases of chronic wounds, diabetic foot ulcers, and pressure sores, which require effective and efficient treatment solutions.

This robust growth is driven by several factors, including an increase in the prevalence of chronic wounds, advancements in debridement technologies, and a rising awareness of the importance of effective wound care management. The demand for innovative and efficient wound debridement products is expected to rise, providing significant opportunities for manufacturers and healthcare providers.

Stakeholders in the wound debridement products market can look forward to a decade of growth and innovation, fueled by ongoing research and development and the increasing need for high-quality wound care solutions.

Debridement treatments are crucial for managing both acute and chronic wounds because they facilitate the removal of biofilms, debris, and necrotic tissue, all of which are necessary for improving wound healing. Effective wound debridement solutions are expected to become more and more necessary as chronic wounds, such as pressure ulcers and diabetic ulcers, become more commonplace worldwide.

Key Points

The United States market leads the North American wound debridement products market in terms of market share in North America. The United States held a healthy market share of 35.9% in 2022. The factors attributed to the growth are the higher geriatric and old population along with the advanced healthcare platforms. The North American region held a market share of 40.7% in 2022.
The German wound debridement products market held an average market share of 6.9% in 2022. The market growth is caused by higher government investment in public healthcare. The European region held a market share of 21.3% in 2022.
The Indian market thrives at a healthy CAGR of 4.9% between 2023 and 2033. The growth is attributed to the increasing number of chronic diseases along with the well-developed research and development programs.
The Chinese market strives at a CAGR of 5.6% between 2023 and 2033.
Based on product type, the mechanical debridement pads type segment held the leading market share of 28.2% in 2022.
Based on application type, chronic ulcers lead as it held a market share of 46.6% in 2022.

Competitive Landscape

The key suppliers focus on ease and affordability. The competitors also merge, acquire, and partner with other companies to increase their supply chain and distribution channel.

Recent Market Developments

Burning Treatment and Wound Debridements – DeRoyal IndustriesInc. Used burn treatment with fluftex gauze rolls & sponges, specialty absorptive dressings with wide mesh, and transeal transparent wound dressing.
Working on Evidence and Experience – BSN Medical has introduced the Cutimed Sorbact, a bacteria-binding dressing especially designed for venous leg ulcers, diabetic foot ulcers, and pressure ulcers.

Key Players:

Smith & Nephew PLC
Derma Sciences, Inc.
Lohmann & Rauscher International Zimmer Biomet
DeRoyal IndustriesInc.
Arobella Medical LLC
Misonix
Söring GmbH
BSN Medical
Molnlycke Healthcare AB

A Full Report – Overview

Key Segments Covered:

By Product Type:

Hydrosurgical Debridement Devices
Low-Frequency Ultrasound Devices
Surgical Wound Debridement Devices
Mechanical Debridement Pads
Traditional Wound Debridement Devices
Larval Therapy

By Application Type:

Chronic Ulcers
Surgical Wounds
Traumatic Wounds
Burn Cases

By End Users:

Hospitals
Ambulatory Surgical Centres
Specialized Clinics
Nursing Facilities
Others

Key Regions Covered:

North America
- United States
- Canada
Latin America
- Brazil
- Mexico
- Rest of Latin America
Europe
- Germany
- United Kingdom
- France
- Spain
- Russia
- Rest of Europe
Japan
Asia Pacific Excluding Japan
- China
- India
- Malaysia
- Singapore
- Australia
- Rest of Asia Pacific Excluding Japan (APEJ)
The Middle East and Africa
- GCC Countries
- Israel
- South Africa
- Middle East and Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Bone Densitometer Devices Market to Reach USD 525 Million by 2033, Expanding at 4.2% CAGR

The global bone densitometer devices market is poised for significant growth, with an estimated value of USD 347.7 million in 2023 and a projected increase to USD 525.0 million by 2033. This growth represents a compound annual growth rate (CAGR) of 4.2% over the forecast period from 2023 to 2033.

Bone densitometer devices play a crucial role in diagnosing and managing bone-related diseases by performing non-invasive procedures to assess bone density and strength. These devices are essential for detecting conditions such as osteoporosis and for evaluating the risk of fractures, thereby aiding in early diagnosis and effective management of bone health.

As awareness of bone health issues rises, so does the demand for accurate and reliable diagnostic tools. Bone densitometers are increasingly used in both clinical and research settings to monitor bone health, especially in populations at higher risk for bone density loss.

Bone densitometers also analyze the risk of developing bone disorders. One of the major market drivers for bone densitometer devices is the rising incidences of knee osteoarthritis. With over 203 knee osteoarthritis cases for every 10,000 persons, 20 years of age and above, bone densitometer devices are expected to be in high demand in the upcoming years.

Moreover, a surge in favorable reimbursement policies by Medicare will likely spur the demand for bone densitometer devices, particularly in countries like India and the U.S. Medicare provides private health insurance plans for the treatment of osteoporosis, which in turn accounts for the increasing expansion of the bone densitometer devices market. Also, many manufacturers are keen on releasing innovative products with novel offerings like low dosage and patented narrow-fan beam technology.

This factor coupled with the rising need for excellent precision and accuracy, high-definition image quality, and faster scans for multiple clinical applications will foster an atmosphere of growth for the target over the projected period.

“Growing bone health awareness, more widespread knowledge about osteoporosis along with initiatives from NGOs and government organizations will likely drive the market growth for the bone densitometer devices over the forecast period,” says an FMI analyst.

Bone Densitometer Devices Market Key Takeaways:

Heightened demand for precise, speedy, and high-quality diagnosis to strengthen the market prospects.
The high cost of the target product and limitations of the DXA technology of bone densitometer devices will impede the market growth.
The U.S. will dominate the global market space with a CAGR of 4.9%.
The market in Germany will be driven by increasing bone disorder awareness programs.
Axial bone densitometer segment will grow at a CAGR of 4.2%
In terms of technology, Dual Energy X-ray absorptiometry will hold about 3/5th of total revenue.

Bone Densitometer Devices Market Competitive Landscape

GE Healthcare, Hologic, Inc., OSI Systems, Inc., Diagnostic Medical Systems Group, Swissray Global Healthcare Holding, Ltd., BeamMed, Ltd., Echolight S.P.A, Scanflex Healthcare AB, Medonica Co., Ltd., XinGaoYi Co., Ltd., Anjue Medical Equipment, Trivitron Healthcare, Eurotec Systems S.r.l, AMPall Co., Ltd., L’acn L’accessorio Nucleare S.R.L, Shenzhen XRAY Electric Co., Ltd., YOZMA BMTech Co., Ltd., Nanoomtech Co., Ltd., Osteosys Corporation, FURUNO Electric Co., Ltd ., and others are some of the major players in the bone densitometer devices market profiled in the full version of the report.

Leading market players are concentrating on improving their product features to expand their business and enter new markets. Strategies like mergers, acquisitions, and distribution agreements are also employed by these enterprises to strengthen their position in the bone densitometer devices market.

A Full Report – Overview

Bone Densitometer Devices Market by Category

By Product:

Peripheral Bone Densitometer
Axial Bone Densitometer

By Technology:

Dual Energy X-ray absorptiometry (DXA)
Peripheral Dual Energy X-Ray
Absorptiometry (pDXA)
Quantitative Ultrasound (QUS)
Others

By End-User:

Hospitals
Orthopedic Clinics
Diagnostic Centers

About Future Market Insights (FMI)

Contact Us:

Portable Ultrasound Bladder Scanner Market Poised for Steady Growth, Projected to Reach USD 188.8 Million by 2034 at a 3.1% of CAGR

The global portable ultrasound bladder scanner market is set to experience consistent growth, with a forecasted valuation of USD 139.9 million in 2024. According to the latest market analysis, the sector is expected to rise at a compound annual growth rate (CAGR) of 3.1%, reaching an estimated USD 188.8 million by 2034.

The demand for portable ultrasound bladder scanners is being driven by their increasing applications in both clinical and emergency settings, where quick and accurate bladder assessments are crucial. This steady growth reflects the broader trend towards portable diagnostic solutions in healthcare.

Notably, 3D portable ultrasound bladder scanners are anticipated to be a major contributor to market expansion. This segment is expected to grow at a robust 3.3% CAGR from 2024 to 2034, underscoring the rising preference for advanced imaging technologies that provide more detailed and accurate results.

Manufacturers of portable ultrasound bladder scanners are focussing on the development of novel and cost-effective bladder scanner devices and are also establishing distribution agreements to increase geographic reach, especially in the Asia Pacific region. This comprehensive report on the global portable ultrasound bladder scanner market studies seven key regions across the globe and includes a market overview along with market forecast, drivers, restraints, trends and opportunities.

The pricing analysis presented in the report includes the weighted average pricing of a single portable ultrasound bladder scanner. A demand-supply gap analysis has been carried out involving both marketplace discussions and desk research to determine pricing premiums. A country-wise analysis scenario includes price projections across various countries. Manufacturers and suppliers play a pivotal role, particularly in the global portable ultrasound bladder scanner market and taking this into consideration, the value chain of the portable ultrasound bladder scanner market has also been analysed in this report.

Our expert analysts have utilised PEST (Political, Economic, Social and Technological) analysis while drafting this report. Besides, a detailed global epidemiology of urological disorders has been included in the report to provide a clear picture of the market scenario across the globe.

In 2020, the items received CE certification and FDA approval from the United States. The least invasive, successful alternative to conventional endoscopic stricture treatments for male anterior urethral strictures is Optilume®.

Moreover, Laborie Medical Technologies Corp. (Laborie) purchased Pelvalon, Inc. in October 2021. Pelvalon produces cutting-edge technologies like the EclipseTM System, a non-surgical, patient-controlled device for women with faecal incontinence (FI).

The portable ultrasonography bladder scanning devices have undergone tremendous progress, which offers additional therapeutic recommendations.

Unique report structure

Primarily, the report on the global portable ultrasound bladder scanner market presents an overview of the entire market for portable ultrasound bladder scanner devices across the globe. The overview is followed by a market taxonomy, where the global portable ultrasound bladder scanner market is segmented based on product, end user, and region. Future Market Insights has leveraged a bottom-up approach to assess market numbers for each product category and a top-down approach to counter-validate the reached numbers.

Macroeconomic indicators such as the healthcare industry outlook, healthcare spending, and prevalence of cancer have been considered to arrive at the indicated market numbers. The analyst team has also provided key strategic recommendations for both existing and new players in the global portable ultrasound bladder scanner market to emerge sustainably profitable. The report further covers the competitive landscape that provides a dashboard view of companies that manufacture and provide services in the global portable ultrasound bladder scanner market.

The report highlights company profiles of some of the key players and a strategic overview of mergers and acquisitions along with their expansion plans across different regions. The subsequent sections analyse the global portable ultrasound bladder scanner market based on product type, end user and region, and present a comprehensive forecast for the period 2016–2026.

A Full Report – Overview

The Portable Ultrasound Bladder Scanner Market is segmented as follows:

By Product

2D Portable Ultrasound Bladder Scanner
3D Portable Ultrasound Bladder Scanner

By End User

Hospitals
Diagnostic Centres
Clinics
Ambulatory Surgical Centres

By Region

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Infrared Search and Track (IRST) Systems Market – Key Players are Adopting Different Growth Strategies to Maintain Their Global Dominance

Over the next several years, it is anticipated that the infrared search and track (IRST) systems market would grow dramatically, with a projected value of US$ 10.4 billion by 2033. For the years 2023 to 2033, an excellent compound annual growth rate (CAGR) of about 4.5% is anticipated. It is projected that the market will reach around US$ 6.7 billion by 2023, offering a substantial absolute dollar potential of US$ 3.7 billion over the course of the evaluation period.

They aren’t thought to be the best at recognizing and identifying cutting-edge planes and missiles. IRST systems have the potential to identify targets as a substitute for radar-based systems, which depend on identifying the heat signatures released by these objects..

Request a Sample of this Report

Increased use of unmanned aerial vehicles (UAVs) and drones has created a demand for more flexible and accurate target tracking solutions. IRST devices are expected to be practical instruments for keeping an eye on these nimble and swift aerial threats. Since they have the advantage of being inert and difficult to detect, it can be done without revealing the position of the monitoring platform.

Development of air-to-air warfare and rise of complex airborne threats have highlighted the limitations of conventional radar-centric tactics. Situational awareness of IRST systems might be enhanced by providing more sensor data.

It can also aid in target engagement, categorization, and detection that is quicker and more accurate. This is crucial in circumstances when electronic defenses might obstruct the use of radar-based equipment

It is expected to enhance situational awareness and reaction times in demanding and tense situations. A strong emphasis on sensor fusion and integration might increase the utility and significance of IRST systems in addressing today’s contemporary defense issues.

Key Takeaways from Infrared Search and Track (IRST) Systems Market:

The global infrared search and track (IRST) systems industry registered a considerable CAGR of 6% in the historical period from 2018 to 2022.
South Korea infrared search and track (IRST) systems industry is anticipated to create an incremental opportunity of US$ 140.8 million in the review period.
Japan infrared search and track (IRST) systems industry is projected to record a CAGR of 4% in the assessment period.
Based on platform, the airborne segment is estimated to witness a CAGR of 4% in the evaluation period.
In terms of component, the scanning head category is likely to exhibit a CAGR of 2% in the assessment period.

“Due to better data exchange, the current battlespace is developing into a dynamic network of detectors, channels, and command posts. Due to their ability to deliver accurate, real-time infrared data, IRST systems are expected to be crucial in this scenario. Radar systems and other computerized warfare systems are examples of extra sensors that companies can employ to improve the data provided by them.” – Says a lead analyst at Future Market Insights (FMI).

Unlock Granular Understanding: Get Your Personalized Report for Regional Insights and Competitor Dynamics

Competitive Landscape and Regional Insights

The competition analysis reveals a dynamic landscape within the global IRST systems market. Companies are continuously innovating to gain a competitive edge and capture a larger market share. This has led to a surge in research and development activities, fostering the growth of the market.

Region-wise insights indicate varying levels of adoption and growth across different parts of the world. As military modernization efforts continue, various regions are investing in upgrading their defense capabilities, driving the demand for IRST systems.

Enhancing Military Capabilities and Concealment Technology Drive Market Growth

The expansion of the infrared search and track (IRST) systems market can be attributed to several influential factors. These include the growing importance of these systems in contemporary military and defense contexts. One of the key driving forces is the increasing need for enhanced military capabilities, where IRST systems play a crucial role in detecting and tracking potential threats.

Moreover, advancements in concealment technology have led to a reduction in the effectiveness of conventional radar systems. As a result, the reliance on IRST systems has intensified, as they provide an effective alternative for target identification and tracking.

Category-wise Insights and Future Prospects

The market for IRST systems can be categorized based on technology, application, and end-user. These categories provide nuanced insights into the diverse applications of IRST systems across different domains, including naval, airborne, and ground-based systems.

Looking ahead, the global infrared search and track (IRST) systems market is set for a promising future. With the increasing focus on military modernization and the evolving nature of threats, IRST systems are poised to play a pivotal role in defense strategies, further fueling market growth.

Empower Your Strategy: Acquire Our Comprehensive Report Today

Infrared Search and Track (IRST) Systems Market Outlook by Category

By Platform:

Airborne
Naval
Land
Others

By Component:

Scanning Head
Processing & Control Electronics
Control & Display Unit

By End Use:

Defense
Civil

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

About Future Market Insights (FMI)

Contact Us: